Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -169.44% | -174.85% | -2.51% | -4.94% | 61.37% |
| Total Depreciation and Amortization | -13.57% | -11.81% | -24.97% | -23.19% | -3.73% |
| Total Amortization of Deferred Charges | -83.11% | -82.78% | -- | -- | 293.92% |
| Total Other Non-Cash Items | 80.72% | 80.33% | -86.13% | -85.81% | -1,531.32% |
| Change in Net Operating Assets | 547.07% | 556.08% | 30.03% | 28.37% | -105.69% |
| Cash from Operations | 70.81% | 70.23% | -3.77% | -6.23% | -20.70% |
| Capital Expenditure | 16.87% | 15.19% | -41.35% | -44.69% | -16.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -103.85% | -103.93% | -97.14% | -97.07% | 39.59% |
| Cash from Investing | -110.45% | -110.66% | -107.99% | -108.18% | 41.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 87.46% | 87.46% | -91.31% | -91.31% | 9.49% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 116.07% | 116.07% | 231.91% | 231.91% | 3,377.03% |
| Cash from Financing | -37.73% | -36.48% | 2,181.04% | 2,230.20% | 4,839.64% |
| Foreign Exchange rate Adjustments | -- | -- | 5,765.79% | 5,813.16% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.81% | -88.59% | 49.91% | 48.72% | 560.40% |